QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
Top-Rated StocksTop-Rated
NYSE:BDX

Becton, Dickinson and (BDX) Stock Forecast, Price & News

$251.57
+0.29 (+0.12%)
(As of 05/18/2023 ET)
Compare
Today's Range
$249.49
▼
$252.06
50-Day Range
$229.71
▼
$265.32
52-Week Range
$215.90
▼
$269.06
Volume
1.38 million shs
Average Volume
1.11 million shs
Market Capitalization
$71.45 billion
P/E Ratio
47.20
Dividend Yield
1.45%
Price Target
$276.60
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Becton, Dickinson and MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
9.9% Upside
$276.60 Price Target
Short Interest
Healthy
0.92% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.45
Upright™ Environmental Score
News Sentiment
0.48mentions of Becton, Dickinson and in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
11.57%
From $12.19 to $13.60 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.51 out of 5 stars

Medical Sector

75th out of 989 stocks

Surgical & Medical Instruments Industry

9th out of 104 stocks

See Top Rated MarketRank™ Stocks Here

BDX stock logo

About Becton, Dickinson and (NYSE:BDX) Stock

Becton, Dickinson & Co. engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Receive BDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Becton, Dickinson and and its competitors with MarketBeat's FREE daily newsletter.

BDX Stock News Headlines

May 18, 2023 | finance.yahoo.com
BD Launches World's First Spectral Cell Sorter with High-Speed Cell Imaging
May 17, 2023 | msn.com
BD Scores FDA Clearance For Artificial Intelligence Software To Interpret Bacterial Growth
May 18, 2023 | Stansberry Research (Ad)
The gold catalyst we've waited for
Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
May 16, 2023 | it.tmcnet.com
BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics
May 13, 2023 | americanbankingnews.com
Short Interest in Becton, Dickinson and Company (NYSE:BDX) Rises By 23.0%
May 12, 2023 | finance.yahoo.com
Q1 2023 Accelerate Diagnostics Inc Earnings Call
May 9, 2023 | msn.com
Citigroup Maintains Becton Dickinson and (BDX) Neutral Recommendation
May 9, 2023 | americanbankingnews.com
Becton, Dickinson and Company Forecasted to Post Q3 2023 Earnings of $2.86 Per Share (NYSE:BDX)
May 18, 2023 | Behind the Markets (Ad)
[BREAKING] New "Living Software" to Revolutionize Warfare
This breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>
May 8, 2023 | markets.businessinsider.com
Where Becton, Dickinson Stands With Analysts
May 8, 2023 | msn.com
Barclays Maintains Becton Dickinson and (BDX) Overweight Recommendation
May 8, 2023 | finance.yahoo.com
Health Care Collaboration in Denmark Aims to Reduce Medical Waste
May 8, 2023 | americanbankingnews.com
Barclays Boosts Becton, Dickinson and (NYSE:BDX) Price Target to $284.00
May 7, 2023 | seekingalpha.com
Becton, Dickinson and Company (BDX) Q2 2023 Earnings Call Transcript
May 7, 2023 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR) and Becton Dickinson (BDX)
May 5, 2023 | msn.com
Piper Sandler Upgrades Becton Dickinson and (BDX)
May 5, 2023 | americanbankingnews.com
Becton, Dickinson and (NYSE:BDX) Lifted to Overweight at Piper Sandler
May 4, 2023 | marketwatch.com
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors
May 4, 2023 | benzinga.com
Becton, Dickinson Shares Dip Despite Q2 Earnings Beat - Here's The Deatils
May 4, 2023 | finance.yahoo.com
Becton Dickinson (BDX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
May 4, 2023 | finance.yahoo.com
Becton Dickinson CEO: Q2 ‘was another quarter of exceeding expectations’
May 4, 2023 | finance.yahoo.com
BD (BDX) Q2 Earnings Surpass Estimates, FY23 View Revised
May 4, 2023 | seekingalpha.com
Becton, Dickinson and Company 2023 Q2 - Results - Earnings Call Presentation
May 4, 2023 | finance.yahoo.com
BD Reports Second Quarter Fiscal 2023 Financial Results
May 4, 2023 | finance.yahoo.com
Is Becton, Dickinson and Company's (NYSE:BDX) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
May 4, 2023 | finance.yahoo.com
Becton Dickinson raises 2023 profit forecast as demand rebounds
May 4, 2023 | americanbankingnews.com
Becton, Dickinson and Company (NYSE:BDX) Short Interest Update
See More Headlines
Receive BDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Becton, Dickinson and and its competitors with MarketBeat's FREE daily newsletter.

BDX Company Calendar

Ex-Dividend for 3/31 Dividend
3/09/2023
Dividend Payable
3/31/2023
Last Earnings
5/04/2023
Today
5/18/2023
Ex-Dividend for 6/30 Dividend
6/08/2023
Dividend Payable
6/30/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
9/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NYSE:BDX
CUSIP
07588710
CIK
10795
Web
www.bd.com
Phone
(201) 847-6800
Fax
201-847-6475
Employees
77,000
Year Founded
1897

Price Target and Rating

Average Stock Price Forecast
$276.60
High Stock Price Forecast
$295.00
Low Stock Price Forecast
$250.00
Forecasted Upside/Downside
+10.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
8 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$5.33
Trailing P/E Ratio
46.90
Forward P/E Ratio
20.51
P/E Growth
2.04
Net Income
$1.78 billion
Net Margins
8.59%
Pretax Margin
9.31%
Return on Equity
12.98%
Return on Assets
6.19%

Debt

Debt-to-Equity Ratio
0.62
Current Ratio
1.31
Quick Ratio
0.81

Sales & Book Value

Annual Sales
$18.81 billion
Price / Sales
3.77
Cash Flow
$19.53 per share
Price / Cash Flow
12.80
Book Value
$90.44 per share
Price / Book
2.76

Miscellaneous

Outstanding Shares
284,015,000
Free Float
283,135,000
Market Cap
$71.00 billion
Optionable
Optionable
Beta
0.54

Social Links


Key Executives

  • Thomas E. PolenThomas E. Polen
    Chairman, President & Chief Executive Officer
  • Christopher J. DelOreficeChristopher J. DelOrefice
    Chief Financial Officer & Executive Vice President
  • William R. Sigmund
    Chief Medical Officer & Executive Vice President
  • Elizabeth McCombs
    Chief Technology Officer & Executive VP
  • Joseph M. Smith
    Chief Scientific Officer & Senior Vice President

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













BDX Stock - Frequently Asked Questions

Should I buy or sell Becton, Dickinson and stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Becton, Dickinson and in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BDX shares.
View BDX analyst ratings or view top-rated stocks.

What is Becton, Dickinson and's stock price forecast for 2023?

8 brokers have issued 12 month price objectives for Becton, Dickinson and's stock. Their BDX share price forecasts range from $250.00 to $295.00. On average, they anticipate the company's share price to reach $276.60 in the next twelve months. This suggests a possible upside of 9.8% from the stock's current price.
View analysts price targets for BDX or view top-rated stocks among Wall Street analysts.

How have BDX shares performed in 2023?

Becton, Dickinson and's stock was trading at $254.30 at the beginning of the year. Since then, BDX stock has decreased by 0.9% and is now trading at $251.91.
View the best growth stocks for 2023 here.

Are investors shorting Becton, Dickinson and?

Becton, Dickinson and saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 2,620,000 shares, an increase of 23.0% from the April 15th total of 2,130,000 shares. Based on an average daily volume of 1,070,000 shares, the days-to-cover ratio is presently 2.4 days. Approximately 0.9% of the company's shares are short sold.
View Becton, Dickinson and's Short Interest.

When is Becton, Dickinson and's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our BDX earnings forecast.

How were Becton, Dickinson and's earnings last quarter?

Becton, Dickinson and Company (NYSE:BDX) released its quarterly earnings results on Thursday, May, 4th. The medical instruments supplier reported $2.86 EPS for the quarter, beating analysts' consensus estimates of $2.75 by $0.11. The medical instruments supplier earned $4.82 billion during the quarter, compared to the consensus estimate of $4.67 billion. Becton, Dickinson and had a trailing twelve-month return on equity of 12.98% and a net margin of 8.59%. The business's quarterly revenue was up 1.5% compared to the same quarter last year. During the same period last year, the company posted $3.18 earnings per share.
Read the conference call transcript.

How often does Becton, Dickinson and pay dividends? What is the dividend yield for Becton, Dickinson and?

Becton, Dickinson and declared a quarterly dividend on Tuesday, April 25th. Shareholders of record on Friday, June 9th will be given a dividend of $0.91 per share on Friday, June 30th. This represents a $3.64 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date of this dividend is Thursday, June 8th.
Read our dividend analysis for BDX.

What ETFs hold Becton, Dickinson and's stock?

ETFs with the largest weight of Becton, Dickinson and (NYSE:BDX) stock in their portfolio include Direxion Daily S&P 500 Bull 3X (SPXL), Direxion Daily S&P 500 Bull 2X Shares (SPUU), Direxion Daily Healthcare Bull 3x Shares (CURE), iShares U.S. Medical Devices ETF (IHI), Kovitz Core Equity ETF (EQTY), Simplify Health Care ETF (PINK), Subversive Mental Health ETF (SANE) and ClearBridge Dividend Strategy ESG ETF (YLDE).

Is Becton, Dickinson and a good dividend stock?

Becton, Dickinson and (NYSE:BDX) pays an annual dividend of $3.64 per share and currently has a dividend yield of 1.44%. The company has been increasing its dividend for 51 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 68.29%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BDX will have a dividend payout ratio of 26.76% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BDX.

How will Becton, Dickinson and's stock buyback program work?

Becton, Dickinson and announced that its Board of Directors has authorized a stock buyback plan on Thursday, November 4th 2021, which authorizes the company to repurchase 10,000,000 outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company's management believes its stock is undervalued.

What guidance has Becton, Dickinson and issued on next quarter's earnings?

Becton, Dickinson and issued an update on its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share (EPS) guidance of $12.10-$12.32 for the period, compared to the consensus EPS estimate of $12.21. The company issued revenue guidance of $19.20 billion-$19.30 billion, compared to the consensus revenue estimate of $19.22 billion.

What is Tom Polen's approval rating as Becton, Dickinson and's CEO?

136 employees have rated Becton, Dickinson and Chief Executive Officer Tom Polen on Glassdoor.com. Tom Polen has an approval rating of 91% among the company's employees. This puts Tom Polen in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Becton, Dickinson and own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Becton, Dickinson and investors own include Johnson & Johnson (JNJ), AbbVie (ABBV), AT&T (T), NVIDIA (NVDA), Walt Disney (DIS), Abbott Laboratories (ABT), Intel (INTC), Verizon Communications (VZ), Cisco Systems (CSCO) and CVS Health (CVS).

What is Becton, Dickinson and's stock symbol?

Becton, Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

Who are Becton, Dickinson and's major shareholders?

Becton, Dickinson and's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.38%), Price T Rowe Associates Inc. MD (5.26%), State Street Corp (4.47%), Wellington Management Group LLP (3.46%), Geode Capital Management LLC (1.77%) and Providence Capital Advisors LLC (1.58%). Insiders that own company stock include Alexandre Conroy, Betty D Larson, Claire Fraser, David Hickey, James C Lim, Patrick Kaltenbach, Rebecca W Rimel, Rebecca W Rimel, Richard Byrd, Roland Goette, Samrat S Khichi, Thomas E Polen Jr, Thomas J Spoerel and Thomas J Spoerel.
View institutional ownership trends.

How do I buy shares of Becton, Dickinson and?

Shares of BDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Becton, Dickinson and's stock price today?

One share of BDX stock can currently be purchased for approximately $251.91.

How much money does Becton, Dickinson and make?

Becton, Dickinson and (NYSE:BDX) has a market capitalization of $71.55 billion and generates $18.81 billion in revenue each year. The medical instruments supplier earns $1.78 billion in net income (profit) each year or $5.33 on an earnings per share basis.

How many employees does Becton, Dickinson and have?

The company employs 77,000 workers across the globe.

Does Becton, Dickinson and have any subsidiaries?
The following companies are subsidiares of Becton, Dickinson and: Accuri Cytometers, Accuri Cytometers Inc., Alverix Inc, Alverix Inc., Atto Bioscience Inc, BD Holding S. de R.L. de C.V., BD Infection Prevention BV, BD Kiestra BV, BD Kiestra Total Lab Automation, BD Rapid Diagnostic (Suzhou) Co. Ltd., BD San Luis Potosi S.A. de C.V., BD Switzerland Sarl, BD Ventures LLC, BD West Africa Limited, BDX INO LLC, Bard (Thailand) Limited, Bard ASDI Inc., Bard Access Systems Inc., Bard Acquisition Sub Inc., Bard Australia Pty. Limited, Bard Benelux N.V., Bard Brachytherapy Inc., Bard Brasil Indústria e Comércio de Produtos Para a Saúde Ltda., Bard Canada Inc., Bard Chile S.p.A., Bard Czech Republic s.r.o., Bard Devices Inc., Bard Dublin ITC Limited, Bard EMEA Finance Center Sp.z o.o., Bard European Distribution Center N.V., Bard Finance B.V. & Co. KG., Bard Financial Services Ltd., Bard Finland OY, Bard France S.A.S., Bard Global Holdings I LLC, Bard Global Holdings II LLC, Bard Global Holdings III LLC, Bard Healthcare Inc., Bard Healthcare Science (Shanghai) Limited, Bard Hellas S.A., Bard Holding SAS, Bard Holdings Limited, Bard Holdings Netherlands B.V., Bard Hong Kong Limited, Bard IP Holdings Inc., Bard India Healthcare Pvt. Ltd., Bard International Holdings B.V., Bard International Inc., Bard Istanbul Healthcare Limited Company, Bard Korea Ltd., Bard Limited, Bard MRL Acquisition Corp., Bard Malaysia Healthcare Sdn. Bhd., Bard Medica SA, Bard Medical Devices (Beijing) Co. Ltd., Bard Medical R&D (Shanghai) Co. Ltd., Bard Medical SA (Proprietary) Limited, Bard Mexico Realty S. de R.L. de C.V., Bard Norden AB, Bard Norway AS, Bard Pacific Health Care Company Ltd., Bard Peripheral Vascular Inc., Bard Poland Sp. z.o.o., Bard Productos Plasticos e Medicos Ltda., Bard Reynosa S.A. de C.V., Bard S.r.l., Bard Sdn. Bhd., Bard Shannon Limited, Bard Singapore Private Limited, Bard Sourcing Office Singapore Pte. Ltd., Bard Sweden AB, Bard UK Newco Limited, Bard de Espana S.A., Becton Dickinson (Gibraltar) Holdings Ltd., Becton Dickinson (Gibraltar) Limited, Becton Dickinson (Gibraltar) Management Limited, Becton Dickinson (Mauritius) Limited, Becton Dickinson (Pty) Ltd., Becton Dickinson (Thailand) Limited, Becton Dickinson A.G., Becton Dickinson A/S, Becton Dickinson Argentina S.R.L., Becton Dickinson Asia Holdings Ltd., Becton Dickinson Asia Limited, Becton Dickinson Austria GmbH, Becton Dickinson Austria Holdings GmbH, Becton Dickinson B.V., Becton Dickinson B.V. Saudi Limited Company, Becton Dickinson Benelux N.V., Becton Dickinson Biosciences Systems and Reagents Inc., Becton Dickinson Canada Inc., Becton Dickinson Caribe Ltd., Becton Dickinson Croatia d.o.o., Becton Dickinson Czechia s.r.o., Becton Dickinson Dispensing Belgium BVBA, Becton Dickinson Dispensing Denmark A/S, Becton Dickinson Dispensing France SAS, Becton Dickinson Dispensing Ireland Limited, Becton Dickinson Dispensing Norway, Becton Dickinson Dispensing Spain S.L.U., Becton Dickinson Dispensing UK Ltd., Becton Dickinson Distribution Center N.V., Becton Dickinson East Africa Ltd., Becton Dickinson Euro Finance Sarl, Becton Dickinson Europe Holdings S.A.S., Becton Dickinson France S.A.S., Becton Dickinson GSA Beteilgungs GmbH, Becton Dickinson Global Holdings I Inc., Becton Dickinson Global Holdings II LLC, Becton Dickinson Global Holdings IV LLC, Becton Dickinson Global Holdings V LLC, Becton Dickinson Global Holdings VII LLC, Becton Dickinson Global Holdings VIII LLC, Becton Dickinson Global Services Centre Sdn. Bhd, Becton Dickinson GmbH, Becton Dickinson Guatemala S.A., Becton Dickinson Hellas S.A., Becton Dickinson Holdings Limited, Becton Dickinson Holdings Ltd., Becton Dickinson Holdings Pte Ltd., Becton Dickinson Hungary Kft., Becton Dickinson India Private Limited, Becton Dickinson Industrias Cirurgicas Ltda., Becton Dickinson Infusion Therapy AB, Becton Dickinson Infusion Therapy Holdings UK Limited, Becton Dickinson Infusion Therapy Systems Inc., Becton Dickinson Infusion Therapy Systems Inc. S.A. de C.V., Becton Dickinson Infusion Therapy UK, Becton Dickinson Insulin Syringe Ltd., Becton Dickinson International Holdings II Pte Ltd., Becton Dickinson International Holdings III Pte Ltd., Becton Dickinson International Holdings Pte Ltd., Becton Dickinson Israel Ltd., Becton Dickinson Italia S.p.A., Becton Dickinson Ithalat Ihracat Limited Sirketi, Becton Dickinson Korea Holding Inc., Becton Dickinson Korea Ltd., Becton Dickinson Ltd., Becton Dickinson Luxembourg Finance S.a.r.L., Becton Dickinson Luxembourg Global Holdings Sarl, Becton Dickinson Luxembourg Holdings II S.a.r.L, Becton Dickinson Luxembourg Holdings III S.a.r.L, Becton Dickinson Luxembourg Holdings V S.a.r.L., Becton Dickinson Malaysia Inc., Becton Dickinson Management GmbH & Co. KG, Becton Dickinson Matrex Holdings Inc., Becton Dickinson Medical (S) Pte Ltd., Becton Dickinson Medical Devices (Shanghai) Co. Ltd., Becton Dickinson Medical Devices (Suzhou) Co. Ltd., Becton Dickinson Medical Products Pte. Ltd., Becton Dickinson Medical Technology (Jiangsu) Co. Ltd., Becton Dickinson Netherlands Global Holdings II C.V., Becton Dickinson Netherlands Holdings B.V., Becton Dickinson Netherlands Holdings II B.V., Becton Dickinson Norway AS, Becton Dickinson O.Y., Becton Dickinson Overseas Services Ltd., Becton Dickinson Pakistan (Pvt) Ltd., Becton Dickinson Penel Limited, Becton Dickinson Philippines Inc., Becton Dickinson Polska Sp.z.o.o., Becton Dickinson Portugal Unipessoal Lda., Becton Dickinson Pty. Ltd., Becton Dickinson Research Centre Ireland Limited, Becton Dickinson Rowa Germany GmbH, Becton Dickinson Rowa Italy Srl, Becton Dickinson S.A., Becton Dickinson Sample Collection GmbH, Becton Dickinson Scot Financing L.L.P., Becton Dickinson Scot Financing L.P., Becton Dickinson Sdn. Bhd., Becton Dickinson Slovakia s.r.o., Becton Dickinson Sweden AB, Becton Dickinson Sweden Holdings AB, Becton Dickinson Switzerland Global Holdings SarL, Becton Dickinson Technology Campus India, Becton Dickinson U.K. Limited, Becton Dickinson UK Financing I Limited, Becton Dickinson UK Financing II Limited, Becton Dickinson Venezuela C.A., Becton Dickinson Venture LLC, Becton Dickinson Verwaltungs GmbH, Becton Dickinson Vostok LLC, Becton Dickinson Worldwide Investments Sa.r.L., Becton Dickinson Zambia Limited, Becton Dickinson and Company Ltd., Becton Dickinson de Colombia Ltda., Becton Dickinson de Mexico S.A. de C.V., Becton Dickinson del Uruguay S.A., Bee IT Solutions, Benex Ltd., Biometric Imaging, Bridger Biomed Inc., C. R. Bard (Portugal) - Produtos e Artigos Medicos e Farmaceuticos, C. R. Bard Do Brasil Productos Medicos Ltda., C. R. Bard GmbH, C. R. Bard Inc., C. R. Bard Netherlands Sales B.V., C.R. Bard Inc, CME America LLC, CME Ltd., CME Medical (UK) Limited, CME UK (Holdings) Limited, CRISI Medical Systems, CRISI Medical Systems Inc., Caesarea Medical Electronics, Cardal II LLC, Care Fusion Development Private Limited, CareFusion (Barbados) SrL, CareFusion (Shanghai) Commercial and Trading Co. Limited, CareFusion 213 LLC, CareFusion 2200 Inc., CareFusion 2201 Inc., CareFusion 302 LLC, CareFusion 303 Inc., CareFusion Asia (HK) Limited, CareFusion Corporation, CareFusion Corporation., CareFusion D.R. 203 Ltd., CareFusion France 309 S.A.S., CareFusion Israel 330 Ltd., CareFusion Italy 312 S.p.A., CareFusion Manufacturing LLC, CareFusion Mexico 215 S.A. de C.V., CareFusion Netherlands 328 B.V., CareFusion Netherlands 503 B.V., CareFusion Netherlands 504 B.V., CareFusion Netherlands Financing 283 C.V., CareFusion Resources LLC, CareFusion S.A. 319 (Proprietary) Limited, CareFusion Solutions LLC, CareFusion U.K. 244 Limited, CareFusion U.K. 305 Limited, CareFusion U.K. 306 Limited, Carmel Pharma AB, Carmel Pharma Inc, Cato Software Solutions, Cell Analysis Systems Inc, Cellular Research, Cellular Research Inc., Clearstream Technologies Group Limited, Clearstream Technologies Limited, Clontech Laboratories Inc, Corporativo BD de Mexico S. de R.L. de C.V., Critical Device Corporation, Cubex, Cytognos, Cytopeia Inc, DLD (Bermuda) Ltd., DVL Acquisition Sub Inc., Davol Inc., Davol International Limited, Davol Surgical Innovations S.A. de C.V., Difco Laboratories Incorporated, Distribuidora BD Mexico S.A. de C.V., Dutch American Manufacturers (D.A.M.) B.V., Dymax Corporation, Embo Medical Limited, Enturia de Mexico S. de R.L. de C.V., Enturican Inc., FJ International Inc., FlowCardia Inc., FlowCardia LLC, FlowJo LLC, Franklin Lakes Enterprises L.L.C., GSL Solutions, Gamer Lasertechnik GmbH, GenCell Biosystems, GenCell Biosystems Ltd., GeneOhm Sciences Canada ULC, GeneOhm Sciences Inc, Gentest Corporation, Gesco International Inc., Gesco International LLC, Glentech Inc, HandyLab Inc, HandyLab Inc., IBD Holdings LLC, Iontophoretics Corporation, JoHome LLC, Kabushiki Kaisha Medicon (Medicon Inc.), Liberator Health and Education Services Inc., Liberator Health and Wellness Inc., Liberator Medical Holdings Inc., Liberator Medical Supply Inc., Limited Liability Company Bard Rus, Loma Vista Medical Inc., Loma Vista Medical LLC, Luther Medical Products Inc, Lutonix Inc., Med-Design Corporation, Med-Design Investment Holdings Inc., Med-Safe Systems Inc, Med-Safe Systems Inc., MedChem Products Inc., Medafor Inc., Medegen LLC, Medinservice.com Inc., Medivance Inc., NAT Diagnostics Inc., NAT Diagnostics Inc., NOW Medical Distribution Inc., NOW Medical Distribution LLC, Navarre Biomedical LLC, Navarre Biomedical Ltd., Neomend Inc., Nippon Becton Dickinson Company Ltd., Omega Biosystems Incorporated, P.R.C. (Isialys) Societe a responsabilitie limitee, PT Becton Dickinson Indonesia, PharMingen, PharMingen., Plasso Technology Ltd, PreAnalytiX GmbH, Pristine Access Technologies Inc., ProSeed Inc., Procesos para Esterilizacion S.A. de C.V., Productos Bard de Mexico S.A. de C.V., Productos Para el Cuidado de la Salud S.A. de C.V., Puls Medical Devices AS LC, PureWick Corporation, Roberts Laboratories Inc., Rochester Medical Corporation, Rochester Medical Ltd., Saf-T-Med Inc, Safety Syringes Inc., Scanwell Health Inc., Sendal S.L.U., SenoRx Inc., SenoRx LLC, Shield Healthcare Centers Inc., Sirigen Group Limited, Sirigen II Limited, Sirigen Inc., Sistemas Médicos ALARIS S.A. de C.V., Specialized Cooperative Corporation, Specialized Health Products Inc., Specialized Health Products International Inc., Specialized Health Products International LLC, Staged Diabetes Management LLC, Straub Medical AG, Straub Medical AG, Surgical Site Solutions Inc., TVA Medical Inc, TVA Medical Inc., Tepha Inc, Tepha Inc., Tissuemed Ltd., Tri-County Medical & Ostomy Supplies Inc., TriPath Imaging Inc., Tru-Fit Marketing Corporation, Vas-Cath Incorporated, Vascular Pathways Inc., Velano Vascular, Velano Vascular Inc., Venclose Inc., Venetec International Inc., Venetec International LLC, Visitec, Y-Med Inc., Y-Med LLC, and ZebraSci Inc..
Read More
How can I contact Becton, Dickinson and?

Becton, Dickinson and's mailing address is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. The official website for the company is www.bd.com. The medical instruments supplier can be reached via phone at (201) 847-6800 or via fax at 201-847-6475.

This page (NYSE:BDX) was last updated on 5/18/2023 by MarketBeat.com Staff

My Account -